Thyroid Cancer

Latest

Tafinlar + Mekinist Approved for BRAF-Positive Anaplastic Thyroid Cancer

Tafinlar + Mekinist Approved for BRAF-Positive Anaplastic Thyroid Cancer

Study data showed 57% of evaluable patients (N=23) had a partial response and 4% achieved a complete response. Among the 14 responders, 64% did not have significant tumor growths for ≥6 months.

Higher Risk of Aging-Related Morbidities in Thyroid Cancer Survivors

Higher Risk of Aging-Related Morbidities in Thyroid Cancer Survivors

Survivors of thyroid cancer have a higher risk of developing age-associated diseases compared with patients who never had cancer, particularly if they were younger than 40 years at the time of diagnosis.

Benefit From Second Radioiodine Treatment for Differentiated Thyroid Cancer

Benefit From Second Radioiodine Treatment for Differentiated Thyroid Cancer

No clear effect in most cases of a second radioactive iodine (RAI) treatment in patients with differentiated thyroid cancer with biochemical or structural regional incomplete response to initial thyroidectomy and RAI therapy.

Watch and Wait: Examining Rates of Tumor Growth in Active Thyroid Surveillance

Watch and Wait: Examining Rates of Tumor Growth in Active Thyroid Surveillance

No regional or distant metastases developed during active surveillance in low-risk patients.

Structural Disease Risk Stratification in Pediatric Patients With Thyroid Cancer

Structural Disease Risk Stratification in Pediatric Patients With Thyroid Cancer

Revised ATA guidelines have led to an increased interest in risk-adopted management strategies for differentiated thyroid cancer.

Does Thyroxine Tx in Hypothyroidism Cause Thyroid Cancer?

Does Thyroxine Tx in Hypothyroidism Cause Thyroid Cancer?

Irregular users of thyroxine were less likely to develop thyroid cancer compared to regular users.

Radioiodine Therapy and Hemorrhagic Stoke: Are Risk Levels Increased?

Radioiodine Therapy and Hemorrhagic Stoke: Are Risk Levels Increased?

Stroke risk with I-131 therapy for thyroid cancer was examined via 2 cohorts using 1:1 propensity score matching.

USPSTF: No Thyroid Cancer Screening in Asymptomatic Adults

USPSTF: No Thyroid Cancer Screening in Asymptomatic Adults

Thyroid cancer screening in asymptomatic adults was given a D recommendation because of the negative effects of screening outweighing any benefits.

Early Puberty, Endocrine Disruptions Noted With Certain Chemical Exposures

Early Puberty, Endocrine Disruptions Noted With Certain Chemical Exposures

Multiple studies at ENDO 2017 highlighted the dangers linked to both environmental toxin and common household chemical exposure.

Health Care Reform Increases Thyroidectomy Rates for Thyroid Cancer

Health Care Reform Increases Thyroidectomy Rates for Thyroid Cancer

Patients with government subsidized or self-pay insurance were less likely to undergo thyroidectomy for thyroid cancer.

Sign Up for Free e-Newsletters



CME Focus